• Most Popular
  • Most Shared

Watson seeks U.S. approval for generic Lybrel

Thu Mar 13, 2008 4:24pm EDT

Stocks

   

NEW YORK, March 13 (Reuters) - Watson Pharmaceuticals Inc (WPI.N) on Thursday said it had asked U.S. regulators for permission to market its generic form of Wyeth's WYE.N recently launched Lybrel contraceptive.

Stocks

Watson said Wyeth filed suit on Wednesday in Delaware federal court to block Watson from introducing its copycat form of the low-dose oral contraceptive. Watson said the suit, under federal law, automatically will block its generic for up to 30 months.

Cowen and Co has predicted that Lybrel will garner annual sales of $500 million in 2012.

Stocks


More from Reuters

Photo

U.S. official admits security failed in air scare

WASHINGTON (Reuters) - A regional wing of al Qaeda claimed responsibility on Monday for a failed Christmas Day attack on a U.S.-bound passenger plane, saying it was to avenge U.S. attacks on the group in Yemen. | Video

» More Top News
Passengers queue to go through security checks at the departure gate at Gatwick Airport, in southern England December 28, 2009. REUTERS/Luke MacGregor

Travel headaches after scare

The U.S. is stepping up airline security measures following the Christmas bomb scare. Here's what you can expect.  Full Article | Video 

U.S.
A man yells at the site of suicide bomb attack on a procession of Shit'ite Muslims commemorating Ashura in Karachi December 28, 2009. Credit: REUTERS/Athar Hussain

"Worse than an infidel"

Dozens killed as suicide bomber attacks Shi'ite Muslim progression in Pakistan despite thousands of security forces on high alert.   Full Article | Video 

World